SurgRx Raises $20 Million

SurgRx Inc., a Redwood City, Calif.-based developer of laparoscopic vessel fusion tools for surgical hemostasis, has raised $20 million in Series F funding. Hedge fund Magnetar Capital Return was joined by return backers Alta Partners, New Enterprise Associates, California Technology Ventures, Prospect Venture Partners and Trellis Health Ventures. The company has raised around $63 million in total VC funding since 2003.